Drugs / clomiphencitrate
clomiphencitrate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01577472 Comparator | Aug 2013 → Nov 2017 | female infertility, ovarian dysfunction | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | clomiphencitrate | “100mg of clomiphencitrate(Serophene®) are added to a high dose of HMG (450 IU of Merional®) in the early follicular phase of the stimulation (day 3 to 7).” NCT01577472 ↗ |
| Known as | clomiphene citrate | “Randomised controlled trial on the effect of clomiphene citrate and gonadotropin dose on ovarian response markers and IVF outcomes in poor responders.” PMID 33367742 ↗ Mar 2021 |
| Known as | Serophene | “100mg of clomiphencitrate(Serophene®) are added to a high dose of HMG (450 IU of Merional®) in the early follicular phase of the stimulation (day 3 to 7).” NCT01577472 ↗ |
| Route | Oral | “addition of oral medication” PMID 33367742 ↗ Mar 2021 |